AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 12 2021
News
Regulator Reviewing Reports of ‘Rare’ and Serious Condition Linked to Moderna Vaccine
Europe’s drug regulator on Thursday confirmed it is investigating reports of a blood condition in recipients of Moderna’s mRNA COVID-19 vaccine.
According to a bulletin posted by the European Medicines Agency (EMA), it is reviewing six cases of capillary leak syndrome, considered a “very rare disorder,” after they were reported in the EMA’s EudraVigilance database.
“At this stage
The Epoch Times
May 06 2021
News
Moderna claims vaccine 96% effective in teens 12 to 17
Moderna has claimed that its COVID-19 vaccine is effective up to 96% in teens aged 12 to 17, presenting a major boost to hopes of a full-time return to in-person learning in the fall.
The announcement is just one of several major developments Moderna revealed in its Q1 2021 Business Update.
Parents and students alike have complained about the issues faced by studying remotely,
Fox News (Online News)
Oct 20 2021
News
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the
Associated Press
Dec 18 2020
News
FDA grants emergency authorization to Moderna's Covid-19 vaccine
The Food and Drug Administration authorized Moderna's Covid-19 vaccine for emergency use Friday, adding a second vaccine to the country's arsenal to fight the pandemic.
The United States is the first country to greenlight use of Moderna's vaccine, which was developed in part with the National Institutes of Health.
The news was met with optimism. "I've never been more hopeful that
NBC News (Online)
Dec 17 2020
News
Upstart Moderna takes on outsized role in U.S. vaccine effort
The nation’s second coronavirus vaccine, produced by Moderna, could be on its way to thousands of sites nationwide by this weekend — a major accomplishment for a company that has never before brought a product to market.
An independent Food and Drug Administration advisory committee on Thursday endorsed the shot for adults 18 and over, and the agency is expected to issue an emergency
Politico
Dec 07 2020
News
Moderna, Pfizer Won't Attend White House Summit on Vaccines
The two pharmaceutical companies closest to gaining U.S. clearance for a Covid-19 vaccine won’t attend a planned White House summit intended to build confidence in the shots.
Pfizer Inc. said in a statement that it had informed the White House that it wouldn’t attend the Tuesday event. Moderna Inc. executives also won’t be present, according to a person familiar with the matter.
Newsmax (News)
Dec 20 2021
News
Moderna says its booster significantly raises the level of antibodies to thwart Omicron.
A booster shot of the Moderna coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant, the company announced on Monday.
The news arrives as Omicron rapidly advances across the world, and most coronavirus vaccines seem unable to stave off infection from the highly contagious variant.
Moderna’s results show that the currently authorized
New York Times (News)
Nov 16 2020
News
Moderna: Coronavirus vaccine nearly 95% effective in early look
Moderna’s coronavirus vaccine was nearly 95% effective and thwarted severe disease in an interim analysis, the company said Monday, putting a second drugmaker on track to request emergency approval before the end of the year.
The Cambridge, Massachusetts, company said it counted 95 cases within its trial of 30,000 participants. Only five of them were in the vaccine arm of the trial,
Washington Times
Dec 16 2021
News
CDC vaccine advisers vote to recommend Pfizer, Moderna vaccines over J&J's
Vaccine advisers to the US Centers for Disease Control and Prevention voted 15-0 Thursday to change recommendations for Covid-19 vaccines to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson's vaccine.
The new recommendation: "mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 years
CNN (Online News)
Sep 19 2020
News
Moderna President Shoots Down Media's Vaccine Fear-Mongering
In recent days, the liberal media have dedicated a lot of effort into stoking fear the coronavirus vaccines being developed by multiple pharmaceutical companies under the Trump administration’s Operation Warp Speed, which put the full weight of the U.S. government behind developing and distributing a safe and effective vaccine. Of course, they were taking their cues from the Biden campaign and
NewsBusters